{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,20]],"date-time":"2026-11-20T02:18:20Z","timestamp":1795141100610,"version":"4.10.3"},"reference-count":22,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,9]]},"abstract":"<jats:sec>\n                    <jats:title>Purpose:<\/jats:title>\n                    <jats:p>To determine whether aqueous flare reflects intraocular inflammation in treatment-na\u00efve diabetic macular edema (DME) and to examine associations between aqueous cytokines and optical coherence tomography (OCT) biomarkers, using Irvine\u2013Gass syndrome (IGS) and cataract eyes as controls.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>Seventy-six eyes were included (40 DME, 19 IGS, 17 cataract controls). All eyes underwent OCT imaging and laser flare photometry. Aqueous levels of interleukin-6, monocyte chemoattractant protein-1, interferon-\u03b3\u2013inducible protein-10, and vascular endothelial growth factor were measured. OCT biomarkers included hyperreflective foci, ellipsoid zone disruption, and subretinal fluid.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      Interleukin-6 levels differed among groups (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.015), being higher in IGS than controls, while monocyte chemoattractant protein-1 showed a borderline difference (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.054) with higher levels in IGS versus DME (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.008). Interferon-\u03b3\u2013inducible protein-10 did not differ among groups, and vascular endothelial growth factor levels were similar between IGS and DME (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.659). Flare values were higher in IGS than controls (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.039) but did not differ between DME and controls. Compared with IGS, DME eyes more frequently exhibited hyperreflective foci and ellipsoid zone disruption (all\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt;0.05). In DME, hyperreflective foci count correlated with interferon-\u03b3\u2013inducible protein-10 on univariate analysis (r = 0.33,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.05), but this association did not remain significant after multivariate adjustment (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.075).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>In treatment-na\u00efve DME eyes, inflammatory profiles likely reflect an early disease state and may differ from those observed in chronic or previously treated DME. hyperreflective foci may represent an OCT phenotype related to inflammatory signaling, although an independent association with interferon-\u03b3\u2013inducible protein-10 was not confirmed, with potential relevance for future studies. Keywords: aqueous flare, biomarkers, cytokines, diabetic macular edema, inflammation, Irvine\u2013Gass, imaging, optical coherence tomography.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/iae.0000000000004845","type":"journal-article","created":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T18:00:21Z","timestamp":1779818421000},"page":"1532-1539","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["INFLAMMATORY AND IMAGING BIOMARKERS IN TREATMENT-NA\u00cfVE DIABETIC MACULAR EDEMA"],"prefix":"10.1097","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6430-6565","authenticated-orcid":false,"given":"Sibel","family":"Demirel","sequence":"first","affiliation":[{"name":"Department of Ophthalmology, Ankara University Faculty of Medicine, Ankara, Turkey;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00d6zge","family":"Yan\u0131k","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Ankara University Faculty of Medicine, Ankara, Turkey;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Figen","family":"Bat\u0131o\u011flu","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Ankara University Faculty of Medicine, Ankara, Turkey;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klara","family":"Dalva","sequence":"additional","affiliation":[{"name":"Department of Hematology, Ankara University Faculty of Medicine, Ankara, Turkey;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehmet Ali","family":"\u015eekero\u011flu","sequence":"additional","affiliation":[{"name":"Ulucanlar Eye Training and Research Hospital, Ankara, Turkey;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tuna \u00c7elik","family":"B\u00fcy\u00fcktepe","sequence":"additional","affiliation":[{"name":"\u00dcnye State Hospital, Ordu, Turkey; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beyza Do\u011fanay","family":"Erdo\u011fan","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, Ankara University Faculty of Medicine, Ankara, Turkey."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emin","family":"\u00d6zmert","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Ankara University Faculty of Medicine, Ankara, Turkey;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20261120","doi-asserted-by":"crossref","first-page":"556","DOI":"10.2337\/dc11-1909","article-title":"Global prevalence and major risk factors of diabetic retinopathy","volume":"35","author":"Yau","year":"2012","journal-title":"Diabetes Care"},{"key":"R2-20261120","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.preteyeres.2015.08.001","article-title":"The progress in understanding diabetic retinopathy","volume":"51","author":"Stitt","year":"2016","journal-title":"Prog Retin Eye Res"},{"key":"R3-20261120","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.ophtha.2008.09.037","article-title":"Association of vitreous inflammatory factors with diabetic macular edema","volume":"116","author":"Funatsu","year":"2009","journal-title":"Ophthalmology"},{"key":"R4-20261120","doi-asserted-by":"crossref","first-page":"BIO68","DOI":"10.1167\/iovs.17-21769","article-title":"Local and systemic inflammatory biomarkers of diabetic retinopathy: an integrative approach","volume":"58","author":"Vujosevic","year":"2017","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R5-20261120","doi-asserted-by":"crossref","first-page":"3427","DOI":"10.3390\/ijms22073427","article-title":"Involvement of cytokines in the pathogenesis of diabetic macular edema","volume":"22","author":"Noma","year":"2021","journal-title":"Int J Mol Sci"},{"key":"R6-20261120","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.ophtha.2017.08.031","article-title":"OCT biomarkers as functional outcome predictors in diabetic macular edema treated with dexamethasone implant","volume":"125","author":"Zur","year":"2018","journal-title":"Ophthalmology"},{"key":"R7-20261120","first-page":"1519","article-title":"The role of OCT biomarkers and inflammatory factors in the management of diabetic macular edema","volume":"35","author":"Zur","year":"2021","journal-title":"Eye (Lond)"},{"key":"R8-20261120","doi-asserted-by":"crossref","first-page":"213130","DOI":"10.1155\/2013\/213130","article-title":"Inflammation and pharmacological treatment in diabetic retinopathy","volume":"2013","author":"Ka\u0161telan","year":"2013","journal-title":"Mediators Inflamm"},{"key":"R9-20261120","first-page":"2515841420950513","article-title":"Novel imaging biomarkers in diabetic retinopathy and diabetic macular edema","volume":"12","author":"Markan","year":"2020","journal-title":"Ther Adv Ophthalmol"},{"key":"R10-20261120","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1007\/s00417-016-3361-7","article-title":"Multimodal retinal imaging of diabetic macular edema: toward new paradigms of pathophysiology","volume":"254","author":"Midena","year":"2016","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R11-20261120","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s10384-016-0488-3","article-title":"Laser flare photometry: principle and clinical applications","volume":"61","author":"Sawa","year":"2017","journal-title":"Jpn J Ophthalmol"},{"key":"R12-20261120","first-page":"1","article-title":"Laser flare photometry: a noninvasive, objective, and quantitative method to measure intraocular inflammation","volume":"50","author":"Tugal-Tutkun","year":"2010","journal-title":"Int Ophthalmol Clin"},{"key":"R13-20261120","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1136\/bjo.78.9.694","article-title":"Laser flare intensity in diabetics: correlation with retinopathy and aqueous protein concentration","volume":"78","author":"Ino-ue","year":"1994","journal-title":"Br J Ophthalmol"},{"key":"R14-20261120","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1007\/BF02169443","article-title":"Quantitative assessment of aqueous flare intensity in diabetes","volume":"227","author":"Oshika","year":"1989","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R15-20261120","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1177\/112067219900900303","article-title":"Aqueous flare intensity in relation to different stages of diabetic retinopathy","volume":"9","author":"Zaczek","year":"1999","journal-title":"Eur J Ophthalmol"},{"key":"R16-20261120","first-page":"1045","article-title":"Prostaglandins and pseudophakic cystoid macular edema","volume":"96","author":"Miyake","year":"1989","journal-title":"Ophthalmology"},{"key":"R17-20261120","doi-asserted-by":"crossref","first-page":"8154","DOI":"10.1167\/iovs.12-10290","article-title":"Retinal thickness in people with diabetes and minimal or no diabetic retinopathy: Heidelberg spectralis optical coherence tomography","volume":"53","author":"Chalam","year":"2012","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R18-20261120","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1097\/IAE.0b013e3182a48917","article-title":"Retinal morphologic changes and concentrations of cytokines in eyes with diabetic macular edema","volume":"34","author":"Sonoda","year":"2014","journal-title":"Retina"},{"key":"R19-20261120","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.ajo.2017.06.026","article-title":"Diabetic macular edema with and without subfoveal neuroretinal detachment: two different morphologic and functional entities","volume":"181","author":"Vujosevic","year":"2017","journal-title":"Am J Ophthalmol"},{"key":"R20-20261120","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.lfs.2019.04.016","article-title":"Blocking CXCR3 with AMG487 ameliorates blood\u2013retinal barrier disruption in diabetic mice through anti-oxidative mechanisms","volume":"228","author":"Wang","year":"2019","journal-title":"Life Sci"},{"key":"R21-20261120","doi-asserted-by":"crossref","first-page":"491835","DOI":"10.1155\/2013\/491835","article-title":"Hyperreflective intraretinal spots in diabetics without and with nonproliferative diabetic retinopathy: an in vivo study using spectral domain OCT","volume":"2013","author":"Vujosevic","year":"2013","journal-title":"J Diabetes Res"},{"key":"R22-20261120","first-page":"2856","article-title":"Aqueous cytokine and growth factor levels do not reliably reflect those in the vitreous","volume":"17","author":"Ecker","year":"2011","journal-title":"Mol Vis"}],"container-title":["Retina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/IAE.0000000000004845","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,20]],"date-time":"2026-11-20T02:00:12Z","timestamp":1795140012000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/IAE.0000000000004845"}},"subtitle":["Comparison with Irvine\u2013Gass and Cataract Controls"],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":22,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/iae.0000000000004845","relation":{},"ISSN":["0275-004X","1539-2864"],"issn-type":[{"value":"0275-004X","type":"print"},{"value":"1539-2864","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9]]}}}